AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06739889 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOA
Description: ELDOA targtes cervical and upper thoracic spine. ELDOA exercises involves spicific postural holds that improve forward neck posture.The goal of ELDOA is to help reduce stress and increase space in the vertebral joints so that muscles can move freely. The benefits of these stretches include joint mobility, increased fluid absorption in the discs of the spine, flexibility, improved muscle tone, postural alignment, body-mind connection, and coordination. The tension and release created by these stretches helps normalize the posture.
Study NCT06739889 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: upper thoracic mobilization
Description: Upper thoracic mobilization, often known as joint mobilization, is a common technique in manual therapy. In order to preserve or restore joint mobility, this approach glides and uses distraction on the joint surfaces.
Study NCT06740695 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Education group
Description: The training materials were prepared in line with the researchers and expert opinions were obtained. Trainings will be given for two weeks. After the trainings are completed, reminder information will be sent to the pregnant women via text messages every other day to inform them that the trainings are continuing. Reminder information prepared as text messages will be sent to the pregnant women's mobile phones. 4 weeks after the first training, the same training will be reminded again via WhatsApp as a summary training by emphasizing key points.~The trainings will be carried out by an expert researcher in the field. In the training content prepared in line with WhatsApp, the risks that may be seen during pregnancy and Gestational Diabetes Mellitus;~* Sensitivity perception and Seriousness perception, perceived risks that may be seen during pregnancy~* Health motivation perception, the pregnant woman's beliefs and practices regarding being healthy,~* Benefit perception, pregnancy follow
Study NCT06284837 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Access site
Description: The SAFER-TAVI trial is randomized study comparing secondary access via a transradial versus transfemoral approach among patients undergoing transfemoral TAVI for aortic valve disease. Secondary access is gained along with primary access at the commencement of the TAVI procedure and is used for aortography before and after valve deployment and for assessment of the primary femoral access site after closure to confirm haemostasis. For patients assigned to radial access, the radial sheath will be removed using a radial band at the end of the procedure. For patients assigned to femoral access, the puncture site will be obtained under ultrasound guidance and fluoroscopic landmark identification. Unless contraindicated, the use of vascular closure devices will be recommended for all femoral cases. The choice of closure device is at the discretion of the operator. Catheters used in the access groups will be 5 or 6 French size at the discretion of the operator.
Study NCT06738979 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQF3510 (Semaglutide Injection)
Description: Semaglutide injection is a long-acting Glucagon-like peptide-1 (GLP-1) receptor agonist.
Study NCT06738979 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Wegovy®
Description: Active Comparator
Study NCT06739187 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Virtual reality platform on head mounted display
Description: Enhance Virtual Reality platform on a Meta Quest head mounted display
Study NCT06739226 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Antigen-specific CAR T, CTL and DCvac to treat melanoma.
Description: Antigen-specific CAR T, CTL and DCvac to treat melanoma.
Study NCT06739863 — intervention group
Intervention type: OTHER
Intervention: healthcare waste management
Description: To evaluate and compare the healthcare waste management practices in primary and secondary hospital Mianwali.~Focuses on assessing the current methods of waste disposal, segregation, treatment, and overall management in healthcare settings at two different levels of care: primary and secondary hospitals.
Study NCT06739213 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SYHA1813
Description: The starting dose of SYHA1813 is 20mg QD
Study NCT06739213 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Investigator's Choice Treatment
Description: Investigator's Choice Treatment
Study NCT06737900 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: traditional physical therapy
Description: * Heating pad for 10 minutes~* Core stability exercises for 20 minutes with 10 seconds of rest intervals~* Patients were advised to stretch for 5 minutes then perform lumber stability exercises.~* These stability exercises included side bridges, supine extension bridge, straight leg raise in prone lying, alternate arm and leg raise from quadruped position and prone bridges.~Both groups took sessions thrice a week for a total of 4 weeks.
Study NCT06737900 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: jandas approach
Description: * Stretching exercise for erector spinae and back extensors muscles~* Stretching exercises for iliopsoas muscle and rectus femoris muscle~* Strengthening exercise for abdominal muscle and gluteal maximus muscle Stretching exercise was performed actively for 3 repetitions x 1 set and 4 days a week Strengthening exercise was performed for 10 second hold and 10 repetitions. All Exercises was performed 3 times per week for total of 4 weeks
Study NCT06739694 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PNE
Description: A manual therapy(Mulligan´s Mobilization with Movement) and 4 sessions of strenght exercises program was administered for both groups. In addition, a pain neuroscience education protocol was administered for the experimental group for a whole period of 4 weeks (1 session/week, 75mins per session).
Study NCT06739694 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Manual therapy
Description: 5 sessions of Mulligan´s Mobilization with Movement and 4 sessions of strenght exercises
Study NCT06739694 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Manual therapy
Description: 5 sessions of Mulligan´s Mobilization with Movement and 4 sessions of strenght exercises
Study NCT06737523 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CVA
Description: Chiglitazar Sodium in combination with Venetoclax and Azacitidine
Study NCT06738238 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ELDOA
Description: In this, each position will be maintained for 1 minute Level: C0/C1/C2 The patient is side lying with bottom arm folded under the head and maintain the neck in a horizontal position with the spine. the bottom leg is bent to stabilize the torso in a vertical position.~Level: C4/C5 Patient lying in supine position and raise both hand arm towards the roof of the room with extended wrist. Bilateral knee to chest with planter flexion at ankle joint.~Level: C5/C6 Same position as for c4/c5 with the arms will be elevated 120 degree Level C6/C7 Supine position with one arm abducted 90 degree and wrist joint at extension and the other hand abducted 30degrees with wrist joint at extension and one leg knee to chest and one leg raise with knee extension and planter flexion at ankle joint.~Level: T4/T5 Quadruped position with one arm abducted 90degrees with wrist at extension Level: T6/T7. Conventional TX is Hot Pack, Tens for 10min. Patient is assessed through baseline, week 1, week 2 and week 4.
Study NCT06738238 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CORRECTIVE EXERCISES
Description: All position will be held for 10 seconds. Initial phase Duration of this phase is 2 weeks. Exercise 1: lying supine on a foam roll with different abduction angles Exercise 2: side lying with external rotation Exercise 3: side lying with forward flexion Exercise 4: standing diagonal flexion Exercise 5: military press Improvement phase. Duration of this phase is 1 week we only add thera- band and dumbbells to the previously mentioned exercises Exercise 1: side lying external rotation with dumbbell Exercise 2: side lying forward flexion with dumbbell Exercise 3: standing diagonal flexion with thera-band Exercise 4: standing external rotation with thera band. Exercise 5: abduction in sitting on training ball. Exercise 6: lying prone on foam ball with different abduction angles Maintenance phase. Duration of this phase is 1 week. Conventional treatment Hot Pack, Tens for 10 minutes Patient is assessed through baseline, week 1, week 2 and week 4.
Study NCT06740071 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: somatosensory interactive pelvic floor muscle training
Description: synchronized PFMT guidance through a combination of audio and video
Study NCT05202470 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TE
Description: After the first meeting, diabetes education videos prepared in two parts a week will be sent to the mobile phones of the individuals. The video submission will be completed in a total of four weeks.
Study NCT05202470 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CE
Description: After the first meeting, diabetes education videos prepared in two parts a week will be sent to the mobile phones of the individuals. The video submission will be completed in a total of four weeks.
Study NCT05165745 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Individualized Feedback
Description: Participants taking PrEP will receive questionnaires regarding self-reported weekly PrEP adherence; they will then receive individualized text-message or email feedback based on their self-reported adherence.
Study NCT06168227 — intervention group
Intervention type: DRUG
Intervention: Disitamb Vedotin
Description: RC48-ADC based therapy
Study NCT06276660 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: BCTT
Description: Participants will complete the Buffalo Concussion Treadmill Test, which involves individuals walking at 5.8 km/hr. (3.6 mph) at a 0.0% incline (5.1 km/hr. \[3.2 mph\] if below 5' 10 tall), the treadmill incline is increased 1 degree each minute for the first 15 minutes, then speed increased 0.64 km/hr. (0.4 mph) each minute thereafter.
Study NCT06276660 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dynamic ExIT
Description: The modified EXiT test will complete a 12 minute treadmill interval program followed by a dynamic circuit (10 squat jumps, 10 side to side push ups and 10 medicine ball rotations), jump ball toss, zig zag agility and arrow agility. Parameters will be recorded the same as the established dynamic EXiT test; heart rate and RPE will be recorded at 0, 2, 6:30 and 12 minutes of the treadmill program as well as after the second trial of each activity. The time to complete two trials of the zig zag agility and arrow agility will also be recorded.
Study NCT05664243 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous genetically modified gamma-delta T cells
Description: Arm A: Cells will be administered on Day 1 of each of 6, 28-day cycles in combination with TMZ maintenance
Study NCT05664243 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogeneic genetically modified gamma-delta T cells
Description: Phase 1b and Arm B: Cells will be administered on Day 1 of each of 6, 28-day cycles in combination with D1 of TMZ 150mg/m2~Arms C: Cells will be administered on Day 1 of each of 6, 28-day cycles in combination with TMZ maintenance
Study NCT05695209 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coaching and Decision Aid
Description: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
Study NCT04540094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Human albumin
Description: Any preparation of 5% Human Albumin Solution which has marketing authorisation in the UK to be used for this indication and is stocked by local hospital pharmacies at the participating sites, may be prescribed in this study
Study NCT04540094 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Balanced crystalloid solution
Description: Any preparation of intravenous balanced crystalloid which has marketing authorisation in the UK to be used for this indication and is stocked by local hospital pharmacies at the participating sites, may be prescribed in this study.
Study NCT06536231 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning
Description: Remote ischemic conditioning (RIC) procedure comprise three repetitions of brachial cuff inflation to 200 mmHg for five minutes following deflation to 0 mmHg for another five minutes. The procedure overall took 30 minutes.
Study NCT06008912 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Calisthenic Exercises
Description: Exercises for upper extremity, lower extremity and trunk which applying just patient's own body weight via using body mechanics. There is no need for any tools for exercises.
Study NCT06008912 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic Exercises
Description: Exercises which loading cardiovascular, respiratory and muscular system at the same time. Treadmill training will apply in the study.
Study NCT06008912 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic Exercises
Description: Exercises which loading cardiovascular, respiratory and muscular system at the same time. Treadmill training will apply in the study.
Study NCT04591860 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic or robot-assisted hiatal closure (sutures only vs. absorbable mesh vs. pledgeted sutures) and fundoplication according to Toupet
Description: Patients are scheduled to undergo laparoscopic or robot-assisted surgery for a large symptomatic hiatal hernia.The hiatal closure will be done with sutures, pledgeted sutures or absorbable mesh (Phasix™ST mesh). After cruroplasty a fundoplication according to Toupet will be done additionally.
Study NCT06040268 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Advair HFA
Description: 6 puffs (total: salmeterol 126 ug and fluticasone 270 ug) twice daily
Study NCT06040268 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: HFA134a inhaler
Study NCT05272085 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound Guided Lavage
Description: After local anesthesia of subcutaneous tissue, lavage will be performed under the guidance of ultrasound using an 18-gauge needle with injectors filled with 4 ml of saline. The needle will be advanced to the center of the calcific deposit. The injector will be kept as parallel to the ground as possible. The plunger of the injector will be pushed with a gently pressure and then released. Calcific deposits are expected to be filled into the syringe along with saline. It is predicted that the clear saline will gradually turn white and become cloudy due to the incoming calcific deposits. When the color of the liquid becomes cloudy, the syringe will be removed without moving the needle, and a new syringe containing 4 ml saline will be placed in its place. Thus, the aspirated calcific deposits will not be reinjected. The same process will be repeated with a new saline filled syringe. After the procedure, 2 ml dexamethasone and 3 ml lidocaine will be injected in subacromial bursa.
Study NCT05272085 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound Guided Subacromial Bursa Injection
Description: 2 ml dexamethasone and 3 ml %2 lidocaine will be injected in the subacromial bursa using a 21-gauge needle under ultrasound guidance.
Study NCT05504720 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 200 mg flat dose, IV, over 30 minutes; day 1, 22, 43 (8 weeks) pre- and post-surgery, followed by post chemotherapy phase day 1 q3w for 11 cycles; max. 17 applications
Study NCT05504720 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: loading dose 8 mg/kg IV over 90 min: day 1 pre- and post-surgery; maintenance dose 6 mg/kg IV over 30 min: Day 22, 43 pre- and post-surgery; followed by 6 mg/kg post chemotherapy phase, day 1 q3w for 11 cycles; max. 17 applications
Study NCT05504720 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FLOT
Description: Docetaxel 50 mg/m² IV over 1 hour plus Oxaliplatin 85 mg/m² IV over 2 hours plus Folinic Acid 200 mg/m² IV over 1 hour plus 5-FU 2600 mg/m² IV over 24 hours every 2 weeks (day 1, 15, 29, 43) for 8 weeks pre- and 8 weeks post-surgery
Study NCT05011448 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Music Therapeutic Interaction and Verbal Interaction
Description: In both sessions (the Verbal Interaction and the Music Therapeutic Interaction) participants will be asked to perform three piano playing exercises in a fixed order: (1) playing a musical scale, (2) playing a short excerpt from a familiar song, and (3) free improvisation. Both sessions will also include a protocol of verbal instructions given by the therapist before each exercise. In session A ('Verbal Interaction') participants will perform these exercises alone while the therapist is only interacting with them verbally (asking them questions, commenting regarding their performance etc.). In session B ('Music Therapeutic Interaction') participants will perform these exercises while the therapist is interacting with them musically, using various music therapy techniques that are matched and attuned to each patient's playing dynamics and style. This is to reflect the dynamics of the music therapeutic interaction as it occurs in the real world of music therapy practice.
Study NCT06520540 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HDM1002 100 mg QD 12weeks
Description: Participants received maintenance dose of 100 mg HDM1002 administered orally once daily (QD)
Study NCT06520540 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HDM1002 200 mg QD 12weeks
Description: Participants received maintenance dose of 200 mg HDM1002 administered orally once daily (QD)
Study NCT06520540 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HDM1002 400 mg QD 12weeks，Q 2W for titration
Description: Participants received maintenance dose of 400 mg HDM1002 administered orally once daily (QD) Q 2W for titration
Study NCT06520540 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HDM1002 400 mg QD 12weeks，Q 3W for titration
Description: Participants received maintenance dose of 400 mg HDM1002 administered orally once daily (QD) Q 3W for titration
Study NCT06520540 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT04988633 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention CFG App
Description: Online healthy lifestyle education through an App. The intervention will consist of viewing educational videos on diet and exercise through an App. Videos will be uploaded to the app on a weekly basis, lasting 2-3.
Study NCT04988633 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control Group
Description: Standard tips for healthy lifestyles that are carried out in regular Primary Care practice. After day 1, where standard advice is received, follow-up visits are conducted at week 2, week 4, month 3, and month 6.
Study NCT06740071 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: pelvic floor magnetic stimulation therapy
Description: stimulation frequency was set at 10 Hz, with stimulation administered in cycles of 5 seconds on followed by 5 seconds off. Each treatment session lasted 20 minutes, conducted twice a week, for a total of 10-12 sessions
Study NCT06740071 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pelvic floor magnetic stimulation therapy
Description: stimulation frequency was set at 10 Hz, with stimulation administered in cycles of 5 seconds on followed by 5 seconds off. Each treatment session lasted 20 minutes, conducted twice a week, for a total of 10-12 sessions
Study NCT06740071 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: standard pelvic floor muscle training
Description: traditional verbal instructions and paper-based educational materials of PFMT are given to participants.~All patients would receive PFMT under the guidance of digital rectal examination by nurses, and their pelvic floor muscle function was graded according to the Oxford Grading System (grades 0-5), ensuring the correctness of subsequent PFMT.
Study NCT06114836 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Omeprazole
Description: Omeprazole will be the PPI prescribed for 4 weeks.
Study NCT06114836 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: AR formula
Description: Added rice formula will be ordered for 4 weeks.
Study NCT06740682 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Podcast olumlu doğum hikayeler
Description: ositive birth stories were listened to by women who gave birth in the hospital included in the study and created with their permission. The podcast recording was done in a single session. These positive birth stories were expertly reviewed by 3 obstetricians and 3 academics. Each podcast content is 10 to 20 minutes (Cai et al., 2023). A WhatsApp reminder msg will be sent so that the stories are not forgotten.~In addition, the pregnant woman will be contacted by phone and trained to listen (Cai et al., 2023).~Participants will be allowed to listen to the podcasts as much as they want (Cai et al., 2023). After listening to each story, their feedback will be received and the participants' doubts will be clarified. (Cai et al., 2023; Çankaya and Şimşek, 2021; Mousavi et al., 2022).~Based on multimedia principles, podcast positive birth experiences will be prepared (Clark and Mayer, 2023). Week 24, Week 30-32, Week 36-38 First story
Study NCT06740604 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BSD-10CH
Description: The BSD-10CH stimulation was applied five times a week for 4 weeks, with each session lasting 20 minutes per day.
Study NCT06740604 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham BSD-10CH
Description: The Sham BSD-10CH stimulation was applied five times a week for 4 weeks, with each session lasting 20 minutes per day.